Stimulation of fibroblast proliferation by insoluble gadolinium salts

Biological Trace Element Research

Volumn 145, Issue 2, 2012, Pages 257-267

  Bleavins, Katherine ^a   Perone, Patricia ^a   Naik, Madhav ^a   Rehman, Muneeb ^a   Aslam, Muhammad N ^a   Dame, Michael K ^a   Meshinchi, Sasha ^a,b   Bhagavathula, Narasimharao ^a   Varani, James ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Dermal fibroblast; Gadolinium carbonate; Gadolinium phosphate; Gadolinium based contrast agent; Intracellular signaling; Proliferation

Indexed keywords

GADOLINIUM; GELATINASE A; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL SURFACE; CELL SURVIVAL; CELL VIABILITY; CHELATION; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; UPREGULATION;

CALCIUM; CELL PROLIFERATION; CELLS, CULTURED; CONTRAST MEDIA; DERMIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FIBROSIS; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; PHOSPHATIDYLINOSITOL 3-KINASES; RENAL INSUFFICIENCY; SALTS; SOLUBILITY;

EID: 84857361856     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-011-9176-9     Document Type: Article

References (62)

1. Evans CH (ed) (1990) Biochemistry of the lanthanides. In: Biochemistry of the Elements. Plenum Press, New York
2. Gschneidner Jr KA, Eyring L (eds) (2000) Handbook on the Physics and Chemistry of Rare Earths (ed), Amsterdam, The Netherlands: Elsevier Science & Technology Books
3. P Joffe HS Thomsen M Meusel 1998 Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis Acad Radiol 5 7 491 502 9653466 10.1016/S1076-6332(98)80191-8 1:STN:280:DyaK1czhslenug%3D%3D (Pubitemid 28303906)
4. SP Lin JJ Brown 2007 MR contrast agents: physical and pharmacologic basics J Magn Reson Imaging 25 5 884 899 17457803 10.1002/jmri.20955 (Pubitemid 46697558)
5. SK Morcos 2008 Extracellular gadolinium contrast agents: differences in stability Eur J Radiol 66 2 175 179 18343072 10.1016/j.ejrad.2008.01.025 1:STN:280:DC%2BD1c3ntlertg%3D%3D
6. SE Cowper HS Robin SM Steinberg, et al. 2000 Scleromyxoedema-like cutaneous diseases in renal-dialysis patients Lancet 356 9234 1000 1001 11041404 10.1016/S0140-6736(00)02694-5 1:STN:280:DC%2BD3cvptVWgsw%3D%3D
7. RD Swartz LJ Crofford SH Phan, et al. 2003 Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure Am J Med 114 7 563 572 12753880 10.1016/S0002-9343(03)00085-8 (Pubitemid 36577259)
8. T Grobner 2006 Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21 4 1104 1108 16431890 10.1093/ndt/gfk062 1:CAS:528: DC%2BD28XivVOntb8%3D
9. P Marckmann L Skov K Rossen, et al. 2006 Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging J Am Soc Nephrol 17 9 2359 2362 16885403 10.1681/ASN. 2006060601 (Pubitemid 44300951)
10. FA Mendoza CM Artlett N Sandorfi, et al. 2006 Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature Semin Arthritis Rheum 35 4 238 249 16461069 10.1016/j.semarthrit.2005.08.002 (Pubitemid 43185214)
11. P Yerram G Saab PR Karuparthi, et al. 2007 Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure-role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate Clin J Am Soc Nephrol 2 2 258 263 17699422 10.2215/CJN.03250906 1:CAS:528:DC%2BD2sXjs1yktro%3D
12. A Khurana VM Runge M Narayanan, et al. 2007 Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan) Invest Radiol 42 2 139 145 17220732 10.1097/01.rli.0000253505.88945. d5 (Pubitemid 46104895)
13. TA Collidge PC Thomson PB Mark, et al. 2007 Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort Radiology 245 1 168 175 17704357 10.1148/radiol. 2451070353 (Pubitemid 47417800)
14. C Rydahl HS Thomsen P Marckmann 2008 High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent Invest Radiol 43 2 141 144 18197066 10.1097/RLI.0b013e31815a3407 1:CAS:528:DC%2BD1cXmt1KqtA%3D%3D
15. WM Shabana RH Cohan JH Ellis, et al. 2008 Nephrogenic systemic fibrosis: a report of 29 cases AJR Am J Roentgenol 190 3 736 741 18287446 10.2214/AJR.07.3115 (Pubitemid 351304519)
16. R Wertman E Altun DR Martin, et al. 2008 Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities Radiology 248 3 799 806 18632533 10.1148/radiol.2483072093
17. DR Broome 2008 Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting Eur J Radiol 66 2 230 234 18372138 10.1016/j.ejrad.2008.02.011
18. AM McNeill RJ Barr 2002 Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis Int J Dermatol 41 6 364 367 12100695 10.1111/j.1365-4632.2002.1488-3.x (Pubitemid 34863309)
19. BA Neudecker R Stern LA Mark, et al. 2005 Scleromyxedema-like lesions of patients in renal failure contain hyaluronan: a possible pathophysiological mechanism J Cutan Pathol 32 9 612 615 16176298 10.1111/j.0303-6987.2005.00415.x (Pubitemid 41415089)
20. M Edward JA Quinn S Mukherjee, et al. 2008 Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis J Pathol 214 5 584 593 18220317 10.1002/path.2311 1:STN:280:DC%2BD1c7pvFahsg%3D%3D (Pubitemid 351482273)
21. J Varani M DaSilva RL Warner, et al. 2009 Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts Invest Radiol 44 2 74 81 19077912 10.1097/RLI. 0b013e31818f76b5 1:CAS:528:DC%2BD1MXit1ertr8%3D
22. M Edward JA Quinn AD Burden, et al. 2010 Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation Radiology 256 3 735 743 20663970 10.1148/radiol.10091131
23. B Wiesinger R Kehlbach J Bebin, et al. 2010 Effects of MRI contrast agents on human embryonic lung fibroblasts Invest Radiol 45 9 513 519 20661142 10.1097/RLI.0b013e3181eb2fe7 1:CAS:528:DC%2BC3cXpvFKhu70%3D
24. N Bhagavathula M DaSilva MN Aslam, et al. 2009 Regulation of collagen turnover in human skin fibroblasts exposed to a gadolinium-based contrast agent Invest Radiol 44 8 433 439 19561517 10.1097/RLI.0b013e3181a4d7e9 1:CAS:528:DC%2BD1MXoslOgurk%3D
25. P Perone S Weber M DaSilva, et al. 2010 Collagenase activity is suppressed by elevated tissue inhibitor of metalloproteinase-1 (TIMP-1) in human skin exposed to a gadolinium-based MRI contrast agent Invest Radiol 45 42 48 19996758 10.1097/RLI.0b013e3181bf95eb 1:CAS:528:DC%2BD1MXhsF2gtr7O
26. WA High RA Ayers J Chandler, et al. 2007 Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis J Am Acad Dermatol 56 21 26 17097388 10.1016/j.jaad.2006.10.047 (Pubitemid 46017000)
27. WA High RA Ayers SE Cowper 2007 Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis J Am Acad Dermatol 56 710 712 17289213 10.1016/j.jaad.2007.01.022 (Pubitemid 46400200)
28. AS Boyd S Sanyal JL Abraham 2010 Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis-subclinical NSF? J Am Acad Dermatol 62 337 342 19939504 10.1016/j.jaad.2009.04.010 1:CAS:528: DC%2BC3cXisFKltro%3D
29. JL Abraham C Thakral L Skov, et al. 2008 Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis Br J Dermatol 158 273 280 18067485 10.1111/j.1365-2133.2007.08335.x 1:CAS:528:DC%2BD1cXivVSju7s%3D
30. SJ George SM Webb JL Abraham SP Cramer 2010 Synchrotron X-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis Br J Dermatol 163 1077 1081 20560953 10.1111/j.1365-2133.2010.09918.x 1:CAS:528:DC%2BC3cXhsFajsrfJ
31. S Hirano KT Suzuki 1996 Exposure, metabolism, and toxicity of rare earths and related compounds Environ Health Perspect 104 Suppl 1 85 95 8722113 10.1289/ehp.96104s185 1:CAS:528:DyaK28XivVels74%3D (Pubitemid 26123094)
32. EG Heckert S Seal WT Self 2008 Fenton-like reaction catalyzed by the rare earth inner transition metal cerium Environ Sci Technol 42 13 5014 5019 18678042 10.1021/es8001508 1:CAS:528:DC%2BD1cXmtFWgsrk%3D (Pubitemid 351956447)
33. N Li S Wang J Liu, et al. 2010 The oxidative damage in lung of mice caused by lanthanoide Biol Trace Elem Res 134 1 68 78 19582375 10.1007/s12011-009-8448-0 1:CAS:528:DC%2BC3cXivFeltLw%3D
34. T Steger-Hartmann M Raschke B Riefke, et al. 2009 The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis-a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide Exp Toxicol Pathol 61 6 537 552 19131226 10.1016/j.etp.2008.11.004 1:CAS:528:DC%2BC3cXkt1yltw%3D%3D
35. PJ Wermuth F Del Galdo SA Jimenez 2009 Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents Arthritis Rheum 60 5 1508 1518 19404939 10.1002/art.24471
36. F Del Galdo PJ Wermuth S Addya, et al. 2010 NFkappaB activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosis Ann Rheum Dis 69 11 2024 2033 20959327 10.1136/ard.2010.134858
37. N Bhagavathula MK Dame M Dasilva, et al. 2010 Fibroblast response to gadolinium: role for platelet-derived growth factor receptor Invest Radiol 45 12 769 777 20714270 10.1097/RLI.0b013e3181e943d2 1:CAS:528:DC%2BC3cXhs1emt7jM
38. M DaSilva M O'Brien Deming SE Fligiel, et al. 2010 Responses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent: comparison of skin from patients with end-stage renal disease and skin from healthy subjects Invest Radiol 45 11 733 739 20661146 10.1097/RLI.0b013e3181e9436b
39. J Varani P Perone CE Griffiths, et al. 1994 All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently J Clin Invest 94 5 1747 1756 7962521 10.1172/JCI117522 1:CAS:528:DyaK2cXmvFakt74%3D
40. JX Li JC Liu K Wang, et al. 2010 Gadolinium-containing bioparticles as an active entity to promote cell cycle progression in mouse embryo fibroblast NIH3T3 cells J Biol Inorg Chem 15 4 547 557 20076980 10.1007/s00775-010-0622-5 1:CAS:528:DC%2BC3cXlvFGntQ%3D%3D
41. GJ Fisher SC Datta HS Talwar, et al. 1996 Molecular basis of sun-induced premature skin ageing and retinoid antagonism Nature 379 6563 335 339 8552187 10.1038/379335a0 1:CAS:528:DyaK28XotVOmtg%3D%3D (Pubitemid 26033074)
42. J Varani J Shayevitz D Perry, et al. 1990 Retinoic acid stimulation of human dermal fibroblast proliferation is dependent on suboptimal extracellular Ca2+ concentration Am J Pathol 136 6 1275 1281 2356860 1:CAS:528: DyaK3cXltV2htbg%3D (Pubitemid 20210326)
43. H Kitamura S Ichinose T Hosoya, et al. 2007 Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis-elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases Pathol Res Pract 203 8 575 585 17590529 10.1016/j.prp.2007.04.008 1:CAS:528: DC%2BD1cXpvVOisA%3D%3D (Pubitemid 47163498)
44. RH Rice EA Vidrio BM Kumfer, et al. 2009 Generation of oxidant response to copper and iron nanoparticles and salts: stimulation by ascorbate Chem Biol Interact 181 3 359 365 19683516 10.1016/j.cbi.2009.08.007 1:CAS:528: DC%2BD1MXhtFGksrzL
45. BB Newton SA Jimenez 2009 Mechanism of NSF: new evidence challenging the prevailing theory J Magn Reson Imaging 30 6 1277 1283 19937925 10.1002/jmri.21980
46. BP Kumar K Shivakumar CC Kartha, et al. 1996 Magnesium deficiency and cerium promote fibrogenesis in rat heart Bull Environ Contam Toxicol 57 4 517 524 8694866 10.1007/s001289900220 1:CAS:528:DyaK28Xltleiu70%3D (Pubitemid 26284692)
47. SM Valiathan CC Kartha 1990 Endomyocardial fibrosis-the possible connexion with myocardial levels of magnesium and cerium Int J Cardiol 28 1 1 5 2194985 10.1016/0167-5273(90)90002-M 1:STN:280:DyaK3czgslemsg%3D%3D (Pubitemid 20180562)
48. MS Valiathan CC Kartha VK Panday, et al. 1986 A geochemical basis for endomyocardial fibrosis Cardiovasc Res 20 9 679 682 3791358 10.1093/cvr/20.9.679 1:CAS:528:DyaL28XlsFSrsrw%3D (Pubitemid 16013050)
49. R Preeta RR Nair 1999 Stimulation of cardiac fibroblast proliferation by cerium: a superoxide anion-mediated response J Mol Cell Cardiol 31 8 1573 1580 10423354 10.1006/jmcc.1999.0994 1:CAS:528:DyaK1MXks1Gnsb0%3D (Pubitemid 29361123)
50. RR Nair R Preeta G Smitha, et al. 2003 Variation in mitogenic response of cardiac and pulmonary fibroblasts to cerium Biol Trace Elem Res 94 3 237 246 12972691 10.1385/BTER:94:3:237 1:CAS:528:DC%2BD3sXnsFylu7w%3D (Pubitemid 37159521)
51. TJ Haley N Komesu M Efros, et al. 1964 Pharmacology and toxicology of lutetium chloride J Pharm Sci 53 1186 1188 14249433 10.1002/jps.2600531011 1:CAS:528:DyaF2MXlt1yl
52. E Pidcock GR Moore 2001 Structural characteristics of protein binding sites for calcium and lanthanide ions J Biol Inorg Chem 6 5-6 479 489 11472012 1:CAS:528:DC%2BD3MXlsFOnt74%3D (Pubitemid 32822109)
53. Y Huang Y Zhou A Castiblanco, et al. 2009 Multiple Ca(2+)-binding sites in the extracellular domain of the Ca(2+)-sensing receptor corresponding to cooperative Ca(2+) response Biochemistry 48 2 388 398 19102677 10.1021/bi8014604 1:CAS:528:DC%2BD1cXhsFelsL3I
54. DT Ward EM Brown HW Harris 1998 Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro J Biol Chem 273 23 14476 14483 9603961 10.1074/jbc.273.23.14476 1:CAS:528:DyaK1cXjs1Oqsrc%3D (Pubitemid 28319169)
55. 2+-sensing receptor Eur J Pharmacol 447 2-3 271 278 12151018 10.1016/S0014-2999(02)01849-6 1:CAS:528:DC%2BD38XlvVWltbc%3D (Pubitemid 34874460)
56. D Riccardi D Maldonado-Perez 2005 The calcium-sensing receptor as a nutrient sensor Biochem Soc Trans 33 Pt 1 316 320 15667336 1:CAS:528: DC%2BD2MXovFymtw%3D%3D (Pubitemid 40313831)
57. S Pillai DD Bikle 1992 Lanthanum influx into cultured human keratinocytes: effect on calcium flux and terminal differentiation J Cell Physiol 151 3 623 629 1363554 10.1002/jcp.1041510323 1:CAS:528: DyaK38XksVGntbc%3D
58. S Chakrabarty V Radjendirane H Appelman, et al. 2003 Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation Cancer Res 63 1 67 71 12517779 1:CAS:528:DC%2BD3sXjvFKmtQ%3D%3D (Pubitemid 36070421)
59. M Estacion LJ Mordan 1993 Competence induction by PDGF requires sustained calcium influx by a mechanism distinct from storage-dependent calcium influx Cell Calcium 14 6 439 454 8395338 10.1016/0143-4160(93)90003-O 1:CAS:528:DyaK3sXlslCksLo%3D (Pubitemid 23212086)
60. JB Lansman 1990 Blockade of current through single calcium channels by trivalent lanthanide cations. Effect of ionic radius on the rates of ion entry and exit J Gen Physiol 95 4 679 696 2159974 10.1085/jgp.95.4.679 1:CAS:528:DyaK3MXpvVyntA%3D%3D (Pubitemid 20150464)
61. RA Caldwell HF Clemo CM Baumgarten 1998 Using gadolinium to identify stretch-activated channels: technical considerations Am J Physiol 275 2 Pt 1 C619 C621 9688617 1:CAS:528:DyaK1cXlsVCksbw%3D
62. A Palasz P Czekaj 2000 Toxicological and cytophysiological aspects of lanthanides action Acta Biochim Pol 47 4 1107 1114 11996100 1:CAS:528: DC%2BD3MXhsVWqtr0%3D